U.S. Markets closed
  • S&P Futures

    4,174.50
    +5.50 (+0.13%)
     
  • Dow Futures

    34,347.00
    +29.00 (+0.08%)
     
  • Nasdaq Futures

    13,417.50
    +30.50 (+0.23%)
     
  • Russell 2000 Futures

    2,226.90
    +4.20 (+0.19%)
     
  • Crude Oil

    65.65
    +0.28 (+0.43%)
     
  • Gold

    1,846.50
    +8.40 (+0.46%)
     
  • Silver

    27.57
    +0.20 (+0.73%)
     
  • EUR/USD

    1.2149
    +0.0065 (+0.5346%)
     
  • 10-Yr Bond

    1.6350
    -0.0330 (-1.98%)
     
  • Vix

    18.81
    -4.32 (-18.68%)
     
  • GBP/USD

    1.4097
    +0.0046 (+0.3242%)
     
  • USD/JPY

    109.3820
    -0.0520 (-0.0475%)
     
  • BTC-USD

    45,838.12
    -2,417.80 (-5.01%)
     
  • CMC Crypto 200

    1,398.33
    +39.77 (+2.93%)
     
  • FTSE 100

    7,043.61
    +80.28 (+1.15%)
     
  • Nikkei 225

    28,084.47
    +636.47 (+2.32%)
     

Why the Johnson & Johnson Vaccine Is Big News

Chris Hill, The Motley Fool
·20 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

In this episode of MarketFoolery, host Chris Hill is joined by Motley fool analyst Jason Moser to discuss Johnson & Johnson's (NYSE: JNJ) one-shot vaccine getting the green light as the company prepares millions of doses to be deployed. Also, Netflix (NASDAQ: NFLX) cleans up at the Golden Globe Awards, while Disney (NYSE: DIS) has an opportunity to make a splash in April. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.